Rotavirus vaccine - Rhein Biotech
Alternative Names: RotavaxLatest Information Update: 24 Oct 2021
Price :
$50 *
At a glance
- Originator Rhein Biotech
- Class Rotavirus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rotavirus infections
Most Recent Events
- 12 Oct 2006 Discontinued - Preclinical for Rotavirus infections in Germany (unspecified route)
- 31 Oct 2002 Rhein Biotech has been acquired by Berna Biotech
- 16 Jul 2001 New profile